In parallel, ERO1α has also been shown to modulate the tumor immune microenvironment—specifically, it enhances the oxidative folding and secretion of immunosuppressive cytokines such as G-CSF, CXCL1, and CXCL2, which are instrumental in recruiting PMN-MDSCs [25]. The gene discussed is ERO1A; the disease is neoplasm.